Insulin Pumps, Including Sensor-Augmented, Enter Competitive Bidding
This article was originally published in The Gray Sheet
Executive Summary
Now that insulin pumps are part of CMS’ competitive bidding program, there is a possibility of reimbursement reductions down the road. And in a separate process, CMS denied Medtronic’s request to establish a new HCPCS code for sensor-augmented insulin pumps.
You may also be interested in...
CMS Expands Competitive Bidding To Include Insulin Pumps, More CPAP Areas
The US Medicare agency will expand its competitive bidding program for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) to include insulin pumps, and will add 10 new competitive bidding areas for continuous positive airway pressure (CPAP) devices. Many device suppliers, as well as Trump’s HHS Secretary-nominee Tom Price, oppose the bidding program.
CMS Proposes To Deny Most HCPCS Code Requests For DMEPOS Items
CMS met this week, and will again on June 3, to hear arguments in support of establishing new or revised level II HCPCS codes for 33 different durable medical equipment, prosthetics and orthotics items and medical supplies. But in preliminary rulings the agency signaled plans to deny all but two of the requests.
Survey Finds Competitive Bidding Restricts Access To Diabetes Products
The American Association of Diabetes Educators surveyed suppliers participating in the nationwide competitive bidding system for mail-ordered diabetes testing systems and found that they are not offering access to as many brands as they initially promised in their bids.